Cargando…
Structure of the BTB Domain of Keap1 and Its Interaction with the Triterpenoid Antagonist CDDO
The protein Keap1 is central to the regulation of the Nrf2-mediated cytoprotective response, and is increasingly recognized as an important target for therapeutic intervention in a range of diseases involving excessive oxidative stress and inflammation. The BTB domain of Keap1 plays key roles in sen...
Autores principales: | Cleasby, Anne, Yon, Jeff, Day, Philip J., Richardson, Caroline, Tickle, Ian J., Williams, Pamela A., Callahan, James F., Carr, Robin, Concha, Nestor, Kerns, Jeffrey K., Qi, Hongwei, Sweitzer, Thomas, Ward, Paris, Davies, Thomas G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045772/ https://www.ncbi.nlm.nih.gov/pubmed/24896564 http://dx.doi.org/10.1371/journal.pone.0098896 |
Ejemplares similares
-
The synthetic triterpenoids CDDO-TFEA and CDDO-Me, but not CDDO, promote nuclear exclusion of BACH1 impairing its activity
por: Casares, Laura, et al.
Publicado: (2022) -
Synthesis and Anticancer Activity of CDDO and CDDO-Me, Two Derivatives of Natural Triterpenoids
por: Borella, Rebecca, et al.
Publicado: (2019) -
The Triterpenoid CDDO-Me Inhibits Bleomycin-Induced Lung Inflammation and Fibrosis
por: Kulkarni, Ajit A., et al.
Publicado: (2013) -
CDDO-Me: A Novel Synthetic Triterpenoid for the Treatment of Pancreatic Cancer
por: Deeb, Dorrah, et al.
Publicado: (2010) -
Preclinical evidences toward the use of triterpenoid CDDO-Me for solid cancer prevention and treatment
por: Wang, Yan-Yang, et al.
Publicado: (2014)